The United States is faced with an unprecedented epidemic of drug abuse. Every year thousands of Americans visit the emergency departments all over the country with illicit drug related complaints. These drugs have been known to be associated with a range of renal pathologies, from reversible acute kidney injuries to debilitating irreversible conditions like renal infarction. So far, no comprehensive study or systematic review has been published that includes the commonly used street drugs and designer drugs with potential nephrotoxic outcomes.
We conducted a systematic review of published case reports, case series, and cross sectional studies of nephrotoxicities related to drugs of abuse. Literature review was conducted using PubMed/Medline from January 1, 2005 -December 31, 2016 to search for publications related to drug abuse with a defined renal outcome. Publications which reported renal injury in relation to the use of illicit drugs were selected, specifically those cases with raised creatinine levels, clinically symptomatic patients, for instance those with oliguria and proven renal biopsies.
A total of 4798 publications were reviewed during the search process and PRISMA flow chart and Moose protocol regarding systematic reviews were followed. 110 articles were shortlisted for the review. A total of 169 cases from case reports and case series, and 14 case studies were analyzed. Renal manifestations of specific illicit drug abuse were included in this review.
Based on the evidence presented, a wide range of renal manifestations were found to be associated with drug abuse. If the trend of increasing use of illicit drug use continues, it will put a significant percentage of the population at an elevated risk for poor renal outcomes. This study is limited by the nature of the literature reviewed being primarily case reports and case series.
Warner M, Hui Chen L, Makuc DM, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, 1980–2008. 1980;
Abuse S, Administration MHS. Results from the 2013 National Survey on drug use and health: summary of National Findings, NSDUH series H-48, HHS publication no. (SMA) 14-4863. Rockville. MD: Substance Abuse and Mental Health S.
Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. MMWR. Morb Mortal Wkly Rep. 2016;65
U.S Department of Justice, Drug Enforcement Administration.2016 National Drug Threat Assessment Summary 2016.
Valga-Amado F, Monzón-Vázquez TR, Hadad F, Torrente-Sierra J, Pérez-Flores I, Barrientos-Guzmán A. Rhabdomyolysis with acute renal failure secondary to taking methadone. Nefrologia. 2012;32:262–3. PubMed
Ergül DF, Ekemen S, Yelken BB. Synthetic cannabinoid “bonzai” intoxication: six case series. Turk Anesteziyoloji ve Reanimasyon Dern Derg. 2015;43:347–51.
Mcneely J, Parikh S, Valentine C, Haddad N, Shidham G, Rovin B, et al. Bath Salts: A Newly Recognized Cause of Acute Kidney Injury. Nephrol. Artic. ID. Hindawi Publishing Corporation; 2012;2012:560854.
Ago M, Ago K, Hara K, Kashimura S, Ogata M. Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report. Legal Med. 2006;
Jonathan D. Auten, Michael J. Matteucci. Methamphetamine Poisoning. CALL US -The Off. Newsl. Calif. Poison Control Syst. 2008;6.
do Sameiro Faria M, Sampaio S, Faria V, Carvalho E. Nephropathy associated with heroin abuse in Caucasian patients. Nephrol Dial Transplant Oxford University Press. 2003;18:2308–13. CrossRef
Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WHC, Seitz MA, et al. PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol. 2008;88:594–6. PubMed
PRISMA [Internet]. [cited 2017 Jan 18]. Available from: http://www.prisma-statement.org/PRISMAStatement/Default.aspx
Gurney SMR, Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014;26:53. PubMed
Sinangil A, Celik V, Kockar A, Ecder T. Synthetic cannabinoid induced acute Tubulointerstitial nephritis and uveitis syndrome: a case report and review of literature. J Clin Diagnostic Res. 2016;10:31–2.
Habboushe J, Sedor J. Cannabinoid hyperemesis acute renal failure: A common sequela of cannabinoid hyperemesis syndrome. Am J Emerg Med Elsevier Inc. 2014;32(690):e1–690. e2
Dettmeyer RB, Preuß J, Wollersen H, Madea B. Heroin-associated nephropathy. . Expert Opin Drug Saf Taylor & Francis; 2005;4:19–28.
Rao TKS, Nicastri AD, Friedman EA. Natural history of heroin-associated nephropathy. N Engl J Med Massachusetts Medical Society. 1974;290:19–23. CrossRef
Tan AU Jr, Cohen AH, Levine BS. Renal amyloidosis in a drug abuser. J Am Soc Nephrol. 1995;5:1653–8. PubMed
Cooper C, Bilbao JE, Said S, Alkhateeb H, Bizet J, Elfar A, et al. Serum amyloid a renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user. J. Nephropathol. Society of Diabetic Nephropathy. 2013;2:196–200.
Sahni V, Garg D, Garg S, Agarwal SK, Singh NP. Unusual complications of heroin abuse: transverse myelitis, rhabdomyolysis, compartment syndrome, and ARF. Clin Toxicol. 2008;46:153–5. CrossRef
Gupta A, Khaira A, Lata S, Agarwal SK, Tiwari SC. Rhabdomyolysis, acute kidney injury and transverse myelitis due to naive heroin exposure. Saudi J Kidney Dis Transpl. 2011;22:1223–5. PubMed
Garg S, Hoenig M, Edwards EM, Bliss C, Heeren T, Tumilty S, et al. Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection. AIDS Patient Care STDS. Mary Ann Liebert, Inc. 2011;25:135–41.
Bautista JEK, Merhi B, Gregory O, Hu S, Henriksen K, Gohh R. Heroin crystal nephropathy. Clin. Kidney J. Oxford University Press. 2015;8:339–42. CrossRef
Glanzmann C, Frey B, Vonbach P, Meier CR. Drugs as risk factors of acute kidney injury in critically ill children. Pediatr Nephrol. 2015;1:145–51.
Briggs M, Arguin PM. Thrombotic thrombocytopenic purpura ( TTP )– like illness associated with intravenous Opana ER abuse — Tennessee, 2012. MMWR. 2013;62:1–16.
Chiuech CC, Kopin IJ. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J Pharmacol Exp Ther. 1978;205:148–54.
Buettner M, Toennes SW, Buettner S, Bickel M, Allwinn R, Geiger H, et al. Nephropathy in illicit drug abusers: a postmortem analysis. Am J Kidney Dis Elsevier Inc. 2014;63:945–53. CrossRef
Heesch C, Wilhelm C, Ristich J, Adnane J, Bontempo F, Wagner W. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000;83(6):688-695. doi: 10.1136/heart.83.6.688.
Bemanian S, Motallebi M, Nosrati SM. Cocaine-induced renal infarction: report of a case and review of the literature. BMC Nephrol. BioMed Central. 2005;6:10. CrossRef
Madhrira MM, Mohan S, Markowitz GS, Pogue VA, Cheng J-T. Acute bilateral renal infarction secondary to cocaine-induced vasospasm. Kidney Int Elsevier Masson SAS. 2009;76:576–80. CrossRef
Tarrass F, Benjelloun M. Cocaine-induced acute renal failure without rhabdomyolysis. Port J Nephrol Hypert. 2009;23:65–6.
Picazo Sánchez M, Cuxart Pérez M, Martín Romero F. Sans Lorman R. Cocaine use, high blood pressure and chronic kidney disease. Nefrologia. 2010;30:706–7. PubMed
Edmondson DA, Towne JB, Foley DW, Abu-Hajir M, Kochar MS. Cocaine-induced renal artery dissection and thrombosis leading to renal infarction. Wis Med J. 2004;103:66–9.
Furaz K, Carro CB, García AC, José AP, De TJAS. Renal infarction and acute renal failure due to cocaine use. Nefrologia. 2008;28:347–9. PubMed
Gu X, Herrera GA. Thrombotic Microangiopathy in cocaine abuse – associated malignant hypertension report of 2 cases with review of the literature. Arch Pathol Lab Med. 2007;131:1817–20. PubMed
Roth D, Alarcón FJ, Fernandez JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N. Engl. J. Med. Massachusetts medicalSociety. 1988;319:673–7. CrossRef
Botros M, Salloum IM. Acute kidney injury associated with alcohol and cocaine abuse. Addict Disord Their Treat. 2016;15:49–51. CrossRef
Connor ADO, Padilla-jones A, Gerkin RD. Levine M. Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity : a Comparison of Stimulants. 2015:195–200.
Abdul-Karim R, Ryan C, Rangel C, Emmett M. Levamisole-induced vasculitis. Proc. (Bayl. Univ. med. Cent). Baylor Health Care System. 2013;26:163–5.
Trimarchi M, Gregorini G, Facchetti F, Morassi ML, Manfredini C, Maroldi R, et al. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine.
Veronese FV, Dode RSO, Friderichs M, Thomé GG, da Silva DR, Schaefer PG, et al. Cocaine/levamisole-induced systemic vasculitis with retiform purpura and pauci-immune glomerulonephritis. Brazilian J. Med. Biol. Res. = rev. bras. Pesqui. Medicas e biol. Associação Brasileira de Divulgação. Científica. 2016;49:e5244.
Lamia R, Ati Z El, Fatma L ben, Zouaghi K, Smaoui W, Rania K, et al. case report malignant hypertension-associated thrombotic Microangiopathy following cocaine use. Saudi J Kidney Dis Transpl 2016;26:153–156.
Carrara C, Emili S, Lin M, Alpers CE. Necrotizing and crescentic glomerulonephritis with membranous nephropathy in a patient exposed to levamisole-adulterated cocaine. Clin. Kidney J. Oxford University Press. 2016;9:234–8. CrossRef
Veer TV d, Pennings E, JWC T, Korswagen L, Van der VT, Pennings E, et al. levamisole-contaminated cocaine : a hairy affair. BMJ Case Rep. 2015;2015:10–2.
Garg L, Gupta S, Swami A, Zhang P, Louis S. Case report levamisole / cocaine induced systemic Vasculitis and immune complex glomerulonephritis. Case Reports Nephrol. 2015;2015:5. CrossRef
Baptiste GG, Alexopoulos A-S, Masud T, Bonsall JM. Systemic Levamisole-Induced Vasculitis in a Cocaine User without Cutaneous Findings: A Consideration in Diagnosis. Case Rep. Med. Hindawi Publishing Corporation; 2015;2015:3.
Ammar AT, Livak M, Witsil JC, Pharmd ATA, Livak M, Pharmd JCW. Old drug new trick : levamisole-adulterated cocaine causing acute kidney injury ☆. Am J Emerg Med Elsevier B.V. 2015;33(309):e3–309. e4
Luciano RL, Perazella MA. Nephrotoxic effects of designer drugs: synthetic is not better! Nat rev Nephrol. Nat Publ Group. 2014;10:314–24.
Shelton CP, Rosini JM. Multisystem organ failure and death resulting from ingestion of “Molly” (3,4-Methylenedioxymethamphetamine). J Emerg Nurs Emergency Nurses Association. 2015;41:447–50. CrossRef
Santoro JD, Black JM, Lee HL. A case of rhabdomyolysis in the presence of multiple risk factors and Dextroamphetamine use. Am J Med Sci Elsevier Masson SAS. 2013;345:494–6. CrossRef
Ecstasy Overdoses CDC. At a new Year’s eve rave — Los Angeles, California, 2010. MMWR. Morb Mortal Wkly Rep. 2010;59:682–6.
Bingham C, Beaman M, Nicholls AJ, Anthony PP. Nephrology Dialysis Transplantation Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine (‘ecstasy’). Nephrol Dial Transpl. 1998;13:2654–5. CrossRef
Nicol JJE, Yarema MC, Jones GR, Martz W, Purssell RA, MacDonald JC, et al. Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series. Can Med Assoc J Open. 2015;3:E83–90.
Davies O, Batajoo-Shrestha B, Sosa-Popoteur J, Olibrice M. Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA. Acute. Hear Lung J Crit Care. 2014;43:117–9. CrossRef
Peng T-R, Lee M-C, T-W W, Lan C-C. Suspected ketamine-associated lower Uri- nary tract symptoms. Urol J. 2012;11:1508–10.
Argamany JR, Reveles KR, Duhon B. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure. Am. J. Emerg. Med. 2016;34(765):e1–765.e2.
Buser GL, Gerona RR, Horowitz BZ, Vian KP, Troxell ML, Hendrickson RG, et al. Acute kidney injury associated with smoking synthetic cannabinoid. Clin Toxicol. 2014;52:664–73. CrossRef
Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use — multiple states. MMWR. Morb Mortal Wkly Rep. 2013;62:93–8.
Katz KD, Leonetti AL, Bailey BC, Surmaitis RM, Eustice ER, Kacinko S, et al. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center. West. J. Emerg. Med. California Chapter of the American Academy of Emergency Medicine (Cal/AAEM); 2016;17:290–4.
Sherpa D, Paudel BM, Subedi BH, Chow RD. Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high. J community Hosp Intern Med Perspect Co-Action Publishing. 2015;5:27540. CrossRef
Srisung W, Jamal F, Prabhakar S. Synthetic cannabinoids and acute kidney injury. Proc. (Bayl. Univ. Med. Cent). 2015;28:475–7. CrossRef
Thornton SL, Wood C, Friesen MW, Gerona RR. Synthetic cannabinoid use associated with acute kidney injury. Clin. Toxicol. (Phila). 2013;51:189–90. CrossRef
Zhao A, Tan M, Maung A, Salifu M, Mallappallil M. Rhabdomyolysis and acute kidney injury requiring dialysis as a result of concomitant use of atypical neuroleptics and synthetic cannabinoids. Case reports Nephrol. 2015;2015:235982. CrossRef
Smith CD, Williams M, Shaikh M. Novel psychoactive substances: a novel clinical challenge. BMJ Case Rep. 2013;2013:1–3.
Rhidian R, Babu A. Acute kidney injury requiring haemodialysis following ingestion of mephedrone. BMJ case rep. BMJ. Group. 2013;2013:7974.
Feng G, Luo Q, Guo E, Yao Y, Yang F, Zhang B, et al. Multiple organ dysfunction syndrome, an unusual complication of heroin intoxication: a case report and review of literature. Int. J. Clin. Exp. Pathol. e-Century Publishing Corporation. 2015;8:11826–30.
Eede H, Vanden MLJ, Touw DJ, Norris EM. Rhabdomyolysis in MDMA intoxication: A rapid and underestimated killer. “clean” Ecstasy, a safe party drug. J. Emerg. Med. Elsevier Inc. 2012;42:655–8. CrossRef
Vakde T, Diaz M, Uday K, Duncalf R. Rapidly reversible multiorgan failure after ingestion of “Molly” (pure 3,4-methylenedioxymethamphetamine): a case report. J Med Case Rep. BioMed Central. 2014;8:204. CrossRef
Eilert RJ, Kliewer ML. Methamphetamine-induced Rhabdomyolysis. Int Anesthesiol Clin. Spring. 2011;49(2):52-6. doi: 10.1097/AIA.0b013e3181ffc0e5.
Alfaro R, Vasavada N, Paueksakon P, Hernandez GT, Aronoff GR. Cocaine-induced acute interstitial nephritis: a case report and review of the literature. J Nephropathol Society of Diabetic Nephropathy. 2013;2:204–9.
Bahaa Aldeen M, Talibmamury N, Alalusi S, Nadham O, Omer AR, Smalligan RD. When coke is not hydrating: cocaine-induced acute interstitial nephritis. J. Investig. Med. High impact case reports SAGE Publications. 2014;2:1–4.
Fabbian F, Pala M, De Giorgi A, Tiseo R, Molino C, Mallozzi Menegatti A, et al. Left kidney: an unusual site of cocaine-related renal infarction. A case report. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 1):30–3. PubMed
Gelpi R, Taco O, Goma M, Torras J, Poveda R, Alvarez T, et al. Evolución natural de la función renal en el anciano: análisis de factores de mal pronóstico asociados a la enfermedad renal crónica. NEfrología. 2013;33:609–11. PubMed
Goel N, Pullman JM, Coco M. Cocaine and kidney injury: a kaleidoscope of pathology. Clin Kidney J Oxford University Press. 2014;7:513–7. CrossRef
Hirachan P, Agarwal R, Wagner B. Cocaine: a rare cause of left-sided renal infarction. J. Investig. Med. High impact case reports. SAGE Publications. 2015;3:1–4. CrossRef
Rivero M, Karlic A, Navaneethan SD, Singh S. Possible cocaine-induced acute renal failure without rhabdomyolysis. J Nephrol. 2006;19:108–10. PubMed
Carlson AQ, Tuot DS, Jen K-Y, Butcher B, Graf J, Sam R, et al. Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine a series of 4 cases. Medicine (Baltimore). 2014;93:290–7. CrossRef
Díaz HÁ, Callejo AIM, Rodríguez JFG, Pazos LR, Buela IG, Barrera AMB, et al. ANCA-positive vasculitis induced by levamisole-adulterated cocaine and nephrotic syndrome: The kidney as an unusual target. Am. J. Case Rep. International Scientific Literature, Inc. 2013;14:557–61.
Moinuddin I, Madhrira M, Bracamonte E, Thajudeen B, Sussman A. Research and Practice Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis. Pathol. -- Res. Pract. Elsevier GmbH. 2016;212:650–3. CrossRef
Zuin M, Giorgini A, Selmi C, Battezzati PM, Cocchi CA, Crosignani A, et al. Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. Dig Liver Dis. 2009;41:2008–10.
Jabr F, Yu l. Thrombotic microangiopathy associated with opana er intravenous abuse. Leban. Med J. 2016;64:64–6.
Chaudhari S, Wankhedkar K, Popis-matejak B, Baumstein D. Methadone for Fun Sake. Kidneys Are at Stake !!! Am. J. Ther.;23. 2016;23:e1108–9. CrossRef
Riederer AM, Campleman SL, Carlson RG, Boyer EW, Manini AF, Wax PM, et al. Acute poisonings from synthetic cannabinoids - 50 U.S. toxicology investigators consortium registry sites, 2010-2015. MMWR. Morb Mortal Wkly Rep. 2016;65:692–5. CrossRef
Aghabiklooei A, Edalatparvar M, Zamani N, Mostafazadeh B. Prognostic factors in acute methadone toxicity: A 5-year study. J Toxicol Hindawi Publishing Corporation; 2014;2014:341826.
McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and Antineutrophil cytoplasmic antibody associated disease. Am. Soc. Nephrol. American Society of Nephrology. 2011;6:2799–805. CrossRef
Liechti ME, Kunz I, Kupferschmidt H. Acute medical problems due to ecstasy use. Case-series of emergency department visits. Swiss Med Wkly Off J Swiss Soc Infect Dis Swiss Soc Intern Med Swiss Soc Pneumol. 2005;135:652–7.
Jones ESW, Rayner BL. Hypertension, end-stage renal disease and mesangiocapillary glomerulonephritis in methamphetamine users. South African. Med J. 2015;105:199–201.
Price SL, Fisher C, Kumar R, Hilgerson A. Cannabinoid Hyperemesis Syndrome as the Underlying Cause of Intractable Nausea and Vomiting. J. Am. Osteopath. Assoc. American Osteopathic Association; 2011;111:166.
Abodunde OA, Nakda J, Nweke N, Levaka R. Cannabinoid hyperemesis syndrome presenting with recurrent acute. Ren Fail. 2013;4:173–5.
Chang C-C, Hsu Y-J, Chu P, Lin S-H. Repetitive vomiting and acute renal failure as the presenting features of cannabinoid hyperemesis syndrome. J Med Sci. 2013;33:163–5.
Ukaigwe A, Karmacharya P, Donato AA. Gut gone to pot: a case of cannabinoid hyperemesis syndrome due to K2, a synthetic cannabinoid. Case rep. Emerg Med. 2014:167098.
Srihari P, Liu M, Punzell S, Shebak SS, Rea WS. Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury. Prim. care companion CNS Disord. Physicians Postgraduate Press, Inc.; 2016;18.
- Systematic review of nephrotoxicity of drugs of abuse, 2005–2016
Anna P. Shapiro
Antonios H. Tzamaloukas
Joseph I. Shapiro
Zeid J. Khitan
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II